𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

✍ Scribed by B. BRENNER; R. HOFFMAN; H. CARP; M. DULITSKY; J. YOUNIS; THE LIVE-ENOX INVESTIGATORS

Book ID
109148711
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
82 KB
Volume
3
Category
Article
ISSN
1538-7933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind study compari
A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis
✍ Koo; FOR THE OLP302 STUDY GROUP πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 787 KB

This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre